Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

CRISPR/Cas-Assisted Nanoneedle Sensor for Adenosine Triphosphate Detection in Living Cells

A 3d Pt Nanoflowers Decorated Micro-Needle Tip For In Situ Detection Of Cellular Atp Release

3D Bimetallic Au/Pt Nanoflowers Decorated Needle-Type Microelectrode for Direct in Situ Monitoring of ATP Secreted from Living Cells.

A Lithops-Like Pt Nanorods Modified Microelectrode Array For Cellular Atp Release Detection

CRISPR-Cas12a accessory cleavage activity triggering electrochemiluminescence biosensor for adenosine triphosphate detection

Aptamer Assisted CRISPR-Cas12a Strategy for Small Molecule Diagnostics.

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

CRISPR-Cas12a-based Efficient Electrochemiluminescence Biosensor for ATP Detection.

Hollow covalent organic framework-sheltering CRISPR/Cas12a as an in-vivo nanosensor for ATP imaging

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Accelerated Crispr/Cas12a-Based Small Molecule Detection Using Bivalent Aptamer

Universal CRISPR/Cas12a-associated aptasensor suitable for rapid detection of small proteins with a plate reader

A boosting upconversion luminescent resonance energy transfer and biomimetic periodic chip integrated CRISPR/Cas12a biosensor for functional DNA regulated transduction of non-nucleic acid targets

Photocontrolled Nanopipette Biosensor for ATP Gradient Electroanalysis of Single Living Cells

Simultaneous ultrasensitive ADP and ATP quantification based on CRISPR/Cas12a integrated ZIF-90@Ag3AuS2@Fe3O4 nanocomposites

Sensitive Small Molecule Aptasensing based on Hybridization Chain Reaction and CRISPR/Cas12a Using a Portable 3D-Printed Visualizer

Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

Accelerated CRISPR/Cas12a-based small molecule detection using bivalent aptamer.

Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic Acid Targets.